Filing Details
- Accession Number:
- 0001104659-22-071465
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-15 16:25:30
- Reporting Period:
- 2022-06-13
- Accepted Time:
- 2022-06-15 16:25:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1880438 | An2 Therapeutics Inc. | ANTX | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1315082 | Ra Capital Healthcare Fund Lp | 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No | |
1346824 | Ra Capital Management, L.p. | 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No | |
1384859 | Peter Kolchinsky | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No | |
1619841 | M. Rajeev Shah | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No | |
1825376 | Ra Capital Nexus Fund Ii, L.p. | 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-13 | 20,000 | $7.90 | 3,686,663 | No | 4 | P | Indirect | See footnotes |
Common Stock | Acquisiton | 2022-06-14 | 61,424 | $7.97 | 3,748,087 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Footnotes
- These securities include 3,271,051 shares held directly by RA Capital Healthcare Fund, L.P. (the "Fund") and 415,612 shares held by RA Capital Nexus Fund II, L.P. (the "Nexus Fund II").
- This transaction was executed in multiple trades at prices ranging from $7.725 to $8.00; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- These securities include 3,332,475 shares held directly by the Fund and 415,612 shares held by Nexus Fund II.
- RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.